Literature DB >> 11501051

In vitro inhibition of rat monoamine oxidase by liquiritigenin and isoliquiritigenin isolated from Sinofranchetia chinensis.

X Pan1, L D Kong, Y Zhang, C H Cheng, R X Tan.   

Abstract

AIM: To study the inhibition of liquiritigenin (1) and isoliquiritigenin (2) isolated from Sinofranchetia chinensis on rat monoamine oxidase A and B (MAO A and B).
METHODS: Rat brain mitochondrial fraction, prepared by differential centrifugation, was utilized as a source of MAO activity. MAO activity was determined radiochemically with [14C]5-hydroxytryptamine (5-HT) and [14C]beta-phenylethylamine (beta-PEA) used as MAO A or B specific radiolabled substrates, respectively. The Ki and KI values were obtained from Lineweaver-Burk plot using linear regression analysis.
RESULTS: Liquiritigenin and isoliquiritigenin were found to be inhibitory against both MAO A and B in a dose-dependent manner. IC50 (95% of confidence limits) of liquiritigenin and isoliquiritigenin were 32 (26-36) and 13.9 (12.8-15.6) mumol/L for the inhibition of MAO A, and 104.6 (89.0-118.9) and 47.2 (39.5-54.5) mumol/L for that of MAO B, respectively. Lineweaver-Burk transformation of the MAO A inhibition data indicated that the inhibition was non-competitive for both liquiritigenin and isoliquiritigenin whereas their inhibition of MAO B was of mixed type. Regarding MAO A inhibition, the Ki values of liquiritigenin and isoliquiritigenin were 31.5 mumol/L and 14.3 mumol/L, respectively. As to the inhibition of MAO B, the Ki and KI data for liquiritigenin were 164.7 and 15.2 mumol/L, and those for isoliquiritigenin were 62.2 and 9.3 mumol/L, respectively.
CONCLUSION: Liquiritigenin and isoliquiritigen inhibited the activity of MAO A and B in rat brain mitochondria, and the latter was more active than the former.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11501051

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  7 in total

1.  Isoliquiritigenin Provides Protection and Attenuates Oxidative Stress-Induced Injuries via the Nrf2-ARE Signaling Pathway After Traumatic Brain Injury.

Authors:  Man Zhang; Li-Li Huang; Chen-Huai Teng; Fang-Fang Wu; Li-Yun Ge; Yu-Juan Shi; Zheng-Le He; Lei Liu; Cheng-Jie Jiang; Ruo-Nan Hou; Jian Xiao; Hong-Yu Zhang; Da-Qing Chen
Journal:  Neurochem Res       Date:  2018-11-16       Impact factor: 3.996

2.  Cancer chemopreventive activity and metabolism of isoliquiritigenin, a compound found in licorice.

Authors:  Muriel Cuendet; Jian Guo; Yan Luo; Shaonong Chen; Carol P Oteham; Richard C Moon; Richard B van Breemen; Laura E Marler; John M Pezzuto
Journal:  Cancer Prev Res (Phila)       Date:  2010-01-12

3.  Biotransformation of the chemopreventive agent 2',4',4-trihydroxychalcone (isoliquiritigenin) by UDP-glucuronosyltransferases.

Authors:  Jian Guo; Ang Liu; Hongmei Cao; Yan Luo; John M Pezzuto; Richard B van Breemen
Journal:  Drug Metab Dispos       Date:  2008-07-24       Impact factor: 3.922

4.  Protective Effects of Liquiritigenin against Citrinin-Triggered, Oxidative-Stress-Mediated Apoptosis and Disruption of Embryonic Development in Mouse Blastocysts.

Authors:  Chien-Hsun Huang; Wen-Hsiung Chan
Journal:  Int J Mol Sci       Date:  2017-11-27       Impact factor: 5.923

Review 5.  Phytochemical and Pharmacological Role of Liquiritigenin and Isoliquiritigenin From Radix Glycyrrhizae in Human Health and Disease Models.

Authors:  Mahesh Ramalingam; Hyojung Kim; Yunjong Lee; Yun-Il Lee
Journal:  Front Aging Neurosci       Date:  2018-11-01       Impact factor: 5.750

6.  Inhibition of Butyrylcholinesterase and Human Monoamine Oxidase-B by the Coumarin Glycyrol and Liquiritigenin Isolated from Glycyrrhiza uralensis.

Authors:  Geum Seok Jeong; Myung-Gyun Kang; Joon Yeop Lee; Sang Ryong Lee; Daeui Park; MyoungLae Cho; Hoon Kim
Journal:  Molecules       Date:  2020-08-26       Impact factor: 4.411

7.  Isoliquiritigenin, a potent human monoamine oxidase inhibitor, modulates dopamine D1, D3, and vasopressin V1A receptors.

Authors:  Ritu Prajapati; Su Hui Seong; Se Eun Park; Pradeep Paudel; Hyun Ah Jung; Jae Sue Choi
Journal:  Sci Rep       Date:  2021-12-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.